Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02278133
Recruitment Status : Completed
First Posted : October 29, 2014
Last Update Posted : October 9, 2017
Sponsor:
Information provided by (Responsible Party):
Array BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 31, 2016
Actual Study Completion Date : June 23, 2017
Certification/Extension First Submitted : July 17, 2017